Grażyna Lietzau

Type 2 diabetes impairs odour detection, olfactory memory and olfactory neuroplasticity; effects partly reversed by the DPP-4 inhibitor Linagliptin

Grażyna Lietzau, William Davidsson, Claes‐Göran Östenson et al. · Acta Neuropathologica Communications · 2018 · 59 citations · Full text

Medicine, Neuroscience, Pharmacology +17

The effect of DPP-4 inhibition to improve functional outcome after stroke is mediated by the SDF-1α/CXCR4 pathway

Fausto Chiazza, Harald Tammen, Hiranya Pintana et al. · Cardiovascular Diabetology · 2018 · 57 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

Gliptin‐mediated neuroprotection against stroke requires chronic pretreatment and is independent of glucagon‐like peptide‐1 receptor

Vladimer Darsalia, Martin Larsson, Grażyna Lietzau et al. · Diabetes Obesity and Metabolism · 2016 · 42 citations

Medicine, Neuroscience, Pharmacology +17

Type 2 diabetes-induced neuronal pathology in the piriform cortex of the rat is reversed by the GLP-1 receptor agonist exendin-4

Grażyna Lietzau, Thomas Nyström, Claes‐Göran Östenson et al. · Oncotarget · 2016 · 29 citations · Full text

Life Sciences, Endocrinology, Neuroscience +15

Obesity-induced type 2 diabetes impairs neurological recovery after stroke in correlation with decreased neurogenesis and persistent atrophy of parvalbumin-positive interneurons

Hiranya Pintana, Grażyna Lietzau, Ingrid Lovise Augestad et al. · Clinical Science · 2019 · 28 citations · Full text

Medicine, Neurology, Neuroscience +17